Join us on May 6 for a virtual legislative briefing on precision medicine and biomarker testing with @Prostate Cancer Foundation. The briefing will cover the process of prior authorization for insurance approval of biomarker testing and why this can often be a barrier for patients to receive timely access to testing and the appropriate treatment plan.